Lipocine Inc.
LPCN
$3.56
$0.257.55%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 1,514.89% | -- | -- | 13,749.45% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1,514.89% | -- | -- | 13,749.45% | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 1,514.89% | -- | -- | 13,749.45% | -- |
| SG&A Expenses | -23.05% | 0.25% | 4.65% | 22.40% | 27.44% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -30.74% | -32.92% | -14.50% | 0.02% | 9.71% |
| Operating Income | 159.59% | 62.65% | 16.76% | 174.28% | -1.27% |
| Income Before Tax | 178.11% | 66.64% | 13.54% | 190.80% | -2.35% |
| Income Tax Expenses | -100.00% | -- | -- | 0.00% | 20.00% |
| Earnings from Continuing Operations | 178.09% | 66.64% | 13.53% | 190.79% | -2.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 178.09% | 66.64% | 13.53% | 190.79% | -2.35% |
| EBIT | 159.59% | 62.65% | 16.76% | 174.28% | -1.27% |
| EBITDA | 160.38% | 62.73% | 16.81% | 174.55% | -1.06% |
| EPS Basic | 177.61% | 66.99% | 15.30% | 189.41% | -0.77% |
| Normalized Basic EPS | 177.67% | 66.99% | 15.32% | 189.40% | -0.75% |
| EPS Diluted | 172.52% | 65.32% | 15.94% | 187.19% | 0.05% |
| Normalized Diluted EPS | 173.08% | 66.99% | 15.32% | 188.70% | -0.75% |
| Average Basic Shares Outstanding | 0.60% | 1.05% | 2.08% | 1.55% | 1.55% |
| Average Diluted Shares Outstanding | 6.89% | 1.05% | 2.08% | 2.34% | 1.55% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |